Carregant...
Assessing Similarity to Existing Drugs to Decide Whether to Continue Drug Development
Developing a drug requires large investments, over many years, with dramatic increases in development costs at later stages. Thus, one wants to make a No Go decision on a compound early, unless evidence continues to suggest that the project will ultimately be successful, so that resources can be foc...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3564656/ https://ncbi.nlm.nih.gov/pubmed/23393611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19466315.2012.698933 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|